The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy
COPD, Chronic Obstructive Pulmonary Disease
About this trial
This is an interventional treatment trial for COPD
Eligibility Criteria
Inclusion Criteria:
Have stage II-IV COPD diagnosis Understand and accept oral and written information in English Be capable of handling the AIRVO warm humidifier after instruction >18years of age
Exclusion Criteria:
- Comorbidity (known malignant disease, terminal illness, dementia, uncontrolled mental illness)
- Bronchiectasis without simultaneous COPD diagnosis
- Treatment with BiPAP in the home
- Affected level of consciousness
- Smoking status change during study period
- Inability to provided signed consent
Sites / Locations
- Lutheran hospitalRecruiting
Arms of the Study
Arm 1
Experimental
Prospective Open label
All of the patients that will be Selected to participate in the study will be given an AIRVO humidifier by the study sponsor. Patients will be connected to and instructed in the use of the AIRVO. The total flow will be set at 20-25 L/min, exact flow rate will be dependent on the patient's preference. Optiflow oxygen catheter will be used to ensure against unpleasant sensation due to high flow and to avoid push back in the system. When acceptable flow rated has been established, it is recorded in the patient's folder. The patients is then instructed to use the AIRVO for a minimum eight (8) hour period, preferably at night. Using the humidifier for a longer period of time is allowed. The total number of hours the humidifier was operational will be recorded at the end of the study